ADBP-1 regulates ADR-2 nuclear localization to control editing substrate selection

Berta Eliad,Noa Schneider,Orna Ben-Naim Zgayer,Yarden Amichan,Fabian Glaser,Emily A. Erdmann,Suba Rajendren,Heather A. Hundley,Ayelet Lamm
DOI: https://doi.org/10.1101/2023.05.14.540679
2024-06-09
Abstract:Adenosine-to-inosine (A-to-I) RNA editing, catalyzed by ADAR enzymes, is a prevalent and conserved RNA modification. While A-to-I RNA editing is essential in mammals, in , it is not, making them invaluable for RNA editing research. In , ADR-2 is the sole catalytic A-to-I editing enzyme, and ADR-1 is an RNA editing regulator. ADAR localization is well-studied in humans but not well-established in . In this study, we examine the cellular and tissue-specific localization of ADR-2. We show that while ADR-2 is present in most cells in the embryo, at later developmental stages, its expression is both tissue- and cell-type-specific. Additionally, both ADARs are mainly in the nucleus. ADR-2 is adjacent to the chromosomes during the cell cycle. We show that the nuclear localization of endogenous ADR-2 depends on ADBP-1, not ADR-1. In mutant worms, ADR-2 is mislocalized, while ADR-1 is not, leading to decreased editing levels and editing, mostly in exons, suggesting that ADR-2 is also functional in the cytoplasm. Besides, mutated ADBP-1 affects gene expression. Furthermore, we show that ADR-2 targets adenosines with different surrounding nucleotides in exons and introns. Our findings indicate that ADR-2 cellular localization is highly regulated and affects its function.
Cell Biology
What problem does this paper attempt to address?